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Abstract The pathologic process of otosclerosis is
characterized by an inXammatory lytic phase followed
by an abnormal bone remodeling at very speciWc sites
of predilection. There is a clear genetic predisposition
with about half of all cases occurring in families with
more than one aVected member. Females are aVected
more frequently than males with an approximate 2:1
ratio. N, H, and F measles proteins as well as measles
virus RNA have been demonstrated in osteoblasts,
chondroblasts, and macrophages of the inXammatory
phase of the disease. These observations merely show
an association between measles viruses and otosclero-
sis. In the present study, we tried to prove that there is
a causal relationship: voluntary measles vaccination
has been available in Germany since 1974. In the
absence of oYcial data, we reconstructed the rate of
vaccination coverage between 1974 and 2004 using
information from the Robert Koch Institute (RKI,
Berlin) and from the literature. From the German Fed-
eral OYce of Statistics, we received the data of 64,112
patients who had been hospitalized between 1993 and
2004 and in whom otosclerosis (ICD-9: 387; ICD-10:
H80) had been conWrmed. We calculated the eVect of
measles vaccination on the incidence of hospital treat-
ments for otosclerosis in the period from 1993 to 2004
in Germany. For this purpose, we divided the female
and male otosclerosis patients treated as inpatients
each year in the observation period into two age
groups: those up to 25 years, who had in most cases
been vaccinated (designated below as “vaccinated
patients”) and those over 25 years who mostly could
not have been vaccinated (designated below as “unvac-
cinated patients”). We calculated the incidence of oto-
sclerosis requiring inpatient treatment for the two age
groups in each year in the period of observation. For
external validation of the study results, the same analy-
sis was carried out in all patients who received inpa-
tient treatment for otitis media in the same period.
Between 1993 and 2004 the incidence of hospital treat-
ments for otosclerosis decreased to a signiWcantly
greater extent in the vaccinated patients than in the
unvaccinated patients. The decline is much greater in
men than in women. A comparable eVect cannot be
demonstrated in patients with otitis media. The results
indicate that measles vaccination in Germany has
resulted in a signiWcant reduction in the number of hos-
pital treatments for otosclerosis in the vaccinated age
groups. We conclude that there is a causal relationship
between measles viruses and the development of oto-
sclerosis.
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Otosclerosis is a disorder of the bony labyrinth, which is
one of the major causes of hearing loss in Caucasians. It
only aVects human beings. Although the clinical course
of progressive conductive, mixed or sensorineural hear-
ing loss associated with otosclerosis is well documented,
its etiology remains unknown. The disease is usually
transmitted as an autosomal-dominant trait with incom-
plete (40%) penetrance. The degree of penetrance is
related to the distribution of the otosclerotic lesions in
the otic capsule. Some lesions are located where they
cannot cause hearing loss [1, 2]. About 8% of male and
12% of female temporal bones from Caucasians show
histological Wndings of otosclerosis. However, only 10%
of them develop clinical symptoms of mainly conduc-
tive or mixed hearing loss when the lesion involves the
stapes, representing up to 1% of the white population
[3, 4].The black population has fewer cases of otosclero-
sis, with only 1% of temporal bones showing histologi-
cal Wndings of the disease [5, 6].
The age at which hearing loss becomes apparent is
variable due to the insidious progression of hearing
loss. However, in many cases hearing loss begins in the
patient’s late teens [1, 6]. About half of the clinical oto-
sclerosis cases report a family history of this condition.
Although genetic, vascular, infectious, and hormonal
factors have been suggested as the underlying mecha-
nism of otosclerosis, this hearing disorder is usually
considered to be an inherited disease. So far, Wve
genetic loci have been mapped, although none has
been cloned [7–10].
In the white population, 90% of the otosclerotic
lesions are located in the area of the oval window caus-
ing mainly conductive hearing loss by Wxation of the
stapes [3–5]. Clinically, females are aVected twice as
often as males [11, 12]. The conductive component of
hearing loss in otosclerosis can be successfully elimi-
nated by removing the Wxed stapes and insertion of a
stapes prosthesis. In Germany, this operation is per-
formed during hospitalization for 2–3 days. From vari-
ous industrial countries, there are reports of a
continuous decline in the number of stapes operations,
which makes it diYcult to teach this delicate surgical
procedure in certain areas [13, 14]. In Denmark, the
total number of stapes operations has shown a sus-
tained decrease of 32% during the last two decades (P.
Bretlau, Copenhagen, personal communication).
Moreover, a striking shift to older patient groups has
been noted and young patients suVering from otoscle-
rosis are becoming rare [15].
During the last 20 years, various research groups
have described an association between measles virus
infection and the inXammatory process in otosclerosis:
in the lytic (inXammatory) phase of otosclerosis (oto-
spongiosis), immunoglobulins are deposited on osteo-
cytes and chondroblasts; a distribution of 80% T
lymphocytes and 20% B lymphocytes indicates the
presence of a viral infection [16, 17]. Using immunohis-
tochemical methods, N, H, and F proteins from mea-
sles virus have been proven in the cytoplasm of
chondroblasts, osteoblasts, and macrophages [18, 19].
Measles virus RNA has been extracted from otoscle-
rotic bone tissue using measles virus-RT-PCR [20–23].
Recently, we performed genotyping of measles virus
obtained from bioptic material of six patients (born
before 1965, operated in 2000). The phylogenetic anal-
ysis resulted in a measles virus genotype A, which was
only present in Middle Europe during 1960s. This
result indicates a measles virus persistence within the
otosclerotic process (submitted for publication). It is
assumed that the persistent MV infection occurs in sus-
ceptible individuals, leading to inXammation and
altered bone metabolism in certain genetically deter-
mined areas of the otic capsule. The hypothesis of a
genetic tissue alteration and exposure to an infectious
agent as prerequisites for development of the disease
would more cogently explain incomplete penetrance of
a dominant gene [13, 18].
Vaccination for measles in Germany was com-
menced in 1974 on a voluntary basis although the ini-
tial application of vaccination was very slow.
Nevertheless, immunization resulted in a remarkable
fall in the annual incidence of measles. Since an animal
model for otosclerosis does not exist and to fullWll
Koch’s postulate (e.g., the isolation of persistent mea-
sles viruses from the infected tissue) is not possible one
method to analyze the causal role of measles viruses in
otosclerosis is to look for a temporal relationship
between immunization and the decline in surgical
cases. Theoretically, the eVect would be detected clini-
cally when the subjects reached the age typical for
manifestation of otosclerotic hearing loss. For exam-
ple, children immunized in 1970s would reach the age
of onset of clinical symptoms in 1990s. Thus, the num-
ber of clinical cases would be expected to have
decreased in 1990s [13].
Methods
Since individual information to test the correlation
between measles virus vaccination and the incidence of
otosclerosis was not available, we used accumulated
data. Since 1993, the diagnoses of all persons receiv-
ing inpatient treatment in Germany based on the123
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as their age and gender have been reported to the Fed-
eral OYce of Statistics (Wiesbaden). From there, we
received the data of 64,112 inpatients in whom otoscle-
rosis (ICD-9: 387, ICD-10: H80) had been conWrmed
between 1993 and 2004. These comprised 40,219
women and 23,893 men; the ratio of women to men was
1.68:1. The diagnosis of otosclerosis is unequivocally
deWned clinically and inpatient treatment for otosclero-
sis is exclusively for stapes surgery to improve hearing.
As described above, only the data from otosclerosis
inpatients was available. There was no information
available on persons receiving outpatient treatment for
otosclerosis. We assumed that the ratio of inpatient to
outpatient treatment and also the notiWcation practices
over the period of observation (1993–2004) were con-
stant, so that a possible eVect of measles vaccination on
the incidence of otoslerosis cases treated as inpatients
can be generally regarded as an indicator for the eVect
of vaccination on the development of otosclerosis.
We obtained data from the Robert Koch Institute
(RKI, Berlin) or from the relevant literature on the
approximate rate of measles vaccination between 1974
and 2004 in Germany. On this basis, the rates of vacci-
nation between 1974 and 2004 were reconstructed.
Vaccine manufacturers or pharmacist associations
were unable to provide any data on the annual quantity
of vaccine sold from which a more precise rate of vacci-
nation could have been calculated for the period
between 1974 and 2004 [24–34].
For each year in the observation period from 1993 to
2004, we divided the otosclerosis inpatients (all patients
together and divided into women and men) into two
age groups: those up to 25 years old who had largely
been vaccinated (designated below as “vaccinated
patients”) and those over 25 years old who mostly
would have remained unvaccinated (designated below
as “unvaccinated patients”). On the basis of the age and
the sex distribution of the population in Germany from
1993 to 2004, we calculated the incidence of otosclerosis
requiring inpatient treatment for the two age groups in
each year of the observation period from the corre-
sponding frequencies [35]. To appraise the precision of
the estimation of the incidence, the 95% conWdence
interval was calculated in accordance with the method
of Clopper and Pearson [36]. Instead of the frequencies
provided by the Federal OYce of Statistics, incidences
were calculated in order to take into consideration the
development of population in the observation period.
If measles vaccination inhibits the development of
otosclerosis, the incidences of otosclerosis in the vacci-
nated patients would have to be lower than in the
unvaccinated patients over the period of observation
(internal validation). In order to rule out the possibility
that an eVect attributed to the measles vaccination has
a diVerent cause in reality, the data from a bacterial ear
infection were accessed (external validation). The Fed-
eral OYce of Statistics provided us with the data from
all persons treated in hospital for otitis media (ICD-9:
382, ICD-10: H66, n = 342,766) in the period from 1993
to 2004. These comprised 161,661 women and 181,105
men. The ratio of women to men was 1:1.2. This data
was processed in the same way as the otoslerosis data
(division into vaccinated and unvaccinated patients
and calculation of the incidence). A possible diVerence
in the incidences as in the two age groups of the oto-
sclerosis patients is not likely to be manifested in the
patients with otitis media, since we assume that the
measles vaccinations does not have any eVect on the
occurrence of a bacterial otitis media. However, if a
diVerence in the incidence is likewise found in this
group of patients, it would be evidence against a corre-
lation between measles vaccination and the occurrence
of otosclerosis and thus, against an involvement of
measles viruses in the development of otosclerosis. The
statistical comparison of frequencies and of incidences
was made by comparing the corresponding conWdence
intervals. A diVerence was considered to be signiWcant
when P < 0.05. The test was two-sided.
Results
Measles vaccination in Germany started in 1974.
According to the literature and data from the RKI
(Berlin) the reconstructed vaccination rate in 1980 was
about 30% and reached 65% in 1982. From then the
vaccination rate with some interruptions slowly
increased up to 80% in 1995. Between 1995 and 2004
the vaccination rate continuously increased up to 90%
(with regional diVerences). The average rate of vacci-
nation between 1974 and 2004 was 72% (Fig. 1).
The frequency and incidence of vaccinated and
unvaccinated inpatients suVering from otosclerosis
between 1993 and 2004 are listed in Table 1. As well
from frequency as from incidence it is obvious that the
decline is signiWcantly greater in the vaccinated
(25 years old or younger) than in the unvaccinated
(older than 25 years) patient group.
Between 1993 and 2004 the incidence of hospital
treatments for otosclerosis has decreased by 42% in the
vaccinated patients and by 16% in the unvaccinated
patients (Fig. 2). Considering the changes of incidence
separately in men and women the incidence of hospital
treatments for otosclerosis has decreased by 27% in the
vaccinated women and by 15% in the unvaccinated123
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the incidence of hospital treatment in vaccinated
patients was 59% as compared to 22% in unvaccinated
patients (Fig. 3). It is notable that the incidence of hos-
pital treatments decreased in the observation period
not only in the vaccinated, but also in the unvaccinated
otosclerosis patients, a phenomenon, which is known as
secular trend. However, the decrease in incidence in the
vaccinated patients is signiWcantly greater than in the
unvaccinated patients. This applies both to women and
men as well as to all patients together.
The frequency and incidence of vaccinated
(·25 years old) and unvaccinated (>25 years old) inpa-
tients suVering from otitis media between 1993 and
2004 are listed in Table 2. The incidence of inpatient
treatment for otitis media decreased by 14% in the vac-
cinated patients but by 17% in the unvaccinated
patients between 1993 and 2004 (women: 10% as com-
pared to 12%; men: 16% as compared to 23%). There
is also a general decrease in the incidence of otitis
media patients (secular trend), but this is even greater
in the unvaccinated group than in the group of patients
vaccinated against measles (Fig. 4).
Discussion
Investigations on preserved or fresh otosclerosis mate-
rial in recent years have revealed measles virus-speciWc
proteins and ribonucleic acids in the cytoplasm of
chondrocytes, osteoblasts, osteoclasts, and macro-
phages. Reference material from healthy temporal
bones or from other ear diseases than otosclerosis did
not contain measles virus proteins or measles virus
RNA [16, 18, 19, 21, 37, 38]. Despite the close correla-
tion between bone disease and demonstration of mea-
sles infection in cells from the inXammation focus, it is
diYcult to understand why the measles virus in the
unequivocally genetically Wxed disease should play a
causal role.
Isolation of measles virus from otosclerotic tissue
(Koch’s postulate) is not possible. There is no animal
model for this disease that occurs exclusively in the
Fig. 1 Measles vaccination in Germany: calculated vaccination
rates between 1974 and 2004 according to to data from the Robert
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Table 1 Frequency and incidence of inpatient treatments for otosclerosis in Germany from 1993–2004
1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004
Frequency Total
Women
Vaccinated 201 203 210 175 185 196 181 125 150 103 123 138 1,990
Unvaccinated 3,327 3,295 3,457 3,483 3,587 3,229 3,063 2,952 2,929 2,996 2,996 2,915 38,229
Men
Vaccinated 174 189 154 135 131 108 125 76 73 62 63 67 1,357
Unvaccinated 1,923 2,022 2,098 2,050 2,048 1,945 1,885 1,697 1,727 1,730 1,742 1,669 22,536
Total
Vaccinated 375 392 364 310 316 304 306 201 223 165 186 205 3,347
Unvaccinated 5,250 5,317 5,555 5,533 5,635 5,174 4,948 4,649 4,656 4,726 4,738 4,584 60,765
Incidence per 10,000 Average Decrease (%)
Women
Vaccinated 1.80 1.85 1.93 1.62 1.69 1.77 1.68 1.16 1.45 0.95 1.15 1.31 1.53 27
Unvaccinated 10.85 10.66 11.12 11.42 11.61 10.32 9.78 9.41 9.73 9.49 9.50 9.23 10.25 15
Men
Vaccinated 1.48 1.63 1.34 1.18 1.15 0.96 1.11 0.67 0.67 0.55 0.57 0.61 1.00 59
Unvaccinated 7.56 7.88 7.95 7.65 7.61 7.16 6.98 6.14 6.48 6.15 6.18 5.92 6.57 22
Total
Vaccinated 1.64 1.74 1.62 1.39 1.42 1.36 1.39 0.91 1.05 0.75 0.85 0.95 1.26 42
Unvaccinated 8.99 9.02 9.35 9.37 9.47 8.63 8.23 7.72 8.04 7.79 7.80 7.53 8.49 16123
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reason, criteria such as those stipulated as alternatives
by B. Hill must have to be used to document the causal
role of measles viruses in the etiology of otosclerosis [39].
Consistency of Wndings: various research groups
arrive at the same immunohistochemical and molecu-
lar biological results at various times at diVerent loca-
tions. As far as we know, there have been no further
investigations apart from the present study on the epi-
demiological examination of the correlation between
measles vaccination and otosclerosis.
Strength of correlation: up to now, proteins and
RNA of measles viruses have only been demonstrated
in otosclerotic bone material from patients with hear-
ing loss due to otosclerosis. In non-otosclerotic bone
material of the same patients or in bone material of
patients with other ear diseases (e.g., otitis media),
none of the investigators succeeded in demonstrating
proteins or RNA from measles viruses.
Temporal relationship: after introduction of measles
vaccination in 1974, there has been a remarkable
decline in the incidence of otosclerosis in the vacci-
nated age groups (present study). A similar eVect can-
not be seen in otitis media patients.
Our epidemiological investigations on the change in
the incidence of otosclerosis treated in hospital have
shown that the incidence decreases to a signiWcantly
greater extent in the vaccinated age group than in the
unvaccinated age group. We conclude from this that
measles vaccination leads to a decrease of otosclerosis.
It is diYcult to identify other reasons, which might
explain why younger patients continuously less fre-
quently came for operation after 1993. Hearing aids
were always an alternative to operations, but it is
improbable that precisely the young patients under
25 years old should decide against an operation in favor
of a hearing aid. For otosclerosis, there is no pharmaco-
therapeutic alternative to surgery. We did not Wnd any
indication that the notiWcation practices in respect of
young otosclerosis patients receiving inpatient treat-
ment had changed in the course of the investigation
period. The change of ICD-9 to ICD-10 in 1999 cannot
explain the diVerent decreases of incidence in the vacci-
nated and unvaccinated otosclerosis patients.
The smaller but clear decrease in the incidence of
treatments for otosclerosis in hospital in the unvacci-
nated patients cannot be explained by a “herd immu-
nity” induced by the measles vaccination. Otosclerosis
is a persistent measles virus infection in which the
infection must have taken place many years before the
occurrence of clinical symptoms. Consequently, most
of the unvaccinated patients had already been infected
before the introduction of measles vaccination and
hence could not proWt from the “herd immunity” deriv-
ing from the vaccination.
Otitis media is a condition caused by a bacterial
infection, which cannot be aVected by measles vaccina-
tion. It must hence be assumed that the very similar
decreases in incidence in unvaccinated otosclerosis
patients and otitis media cases who have been vacci-
nated or not vaccinated are not disease-speciWc, and
constitute a secular trend. In principle, a secular trend
may be due to factors such as changes in health policy,
strategy of treatment, notiWcation practice or preven-
tive health measures. The possible causes must be ana-
lyzed in a future investigation.
If the incidence of otosclerosis in the vaccinated
population has declined signiWcantly due to active
immunization against measles viruses, the measles
virus must play a causal role in the etiology of the
Fig. 2 Percentage change in the incidence of inpatient treatment
for otosclerosis in relation to 1993. Patients over 25 years old
(blue, n = 60,765) were deWned as mainly unvaccinated, and those
up to and including 25 years old (red, n = 3,347) as vaccinated. In
the unvaccinated patients, the incidence decreases by 16%, and












Fig. 3 Percentage change in the incidence of inpatient treatment
for otosclerosis in relation to 1993, data expressed separately for
men and women. In the vaccinated women (broken line, red), the
incidence decreases by 27%, and in the unvaccinated women
(broken line, blue) by 15%. Vaccinated men (solid line, red) show
a decrease of the incidence by 59%, as compared to 22% in the
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up to 70% of cases, it is possible, that the measles virus
binds to genetically (immunologically) preformed
topographical regions of the temporal bone (e.g., ante-
rior part of the oval window, promontory, stapes foot-
plate, round window) [7]. The concomitant occurrence
of a genetically determined high susceptibility for
attachment of measles viruses (speciWc receptors?) and
exogenously inWltrating measles virus induces the pro-
cess of otosclerotic inXammation. If the measles virus is
stopped from penetrating into “loci minoris resisten-
tiae” owing to immunization of the host (vaccination),
the process of bone remodeling cannot be initiated and
the hearing loss due to otosclerosis does not occur. The
measles virus is hence causally responsible for the
development of otosclerosis and adequate vaccination
of the population might prevent the development of
otoslerotic hearing loss [40].
The Wnding that women respond to measles vaccina-
tion signiWcantly less favorably than men (27% as com-
pared to 59%) with regard to the clinical incidence of
otosclerosis is diYcult to interpret. It is known that
Table 2 Frequency and incidence of inpatient treatments for otits media in Germany from 1993–2004
1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004
Frequency Total
Women
Vaccinated 5,134 5,562 5,892 5,947 6,239 6,526 5,824 5,396 4,985 5,075 5,021 4,375 65,976
Unvaccinated 6,747 7,769 9,004 9,248 9,523 9,403 8,950 7,656 7,164 7,277 6,828 6,116 95,685
Men
Vaccinated 6,917 7,485 7,919 7,711 7,901 8,323 7,380 6,787 6,234 6,437 6,344 5,450 84,888
Unvaccinated 7,129 8,233 9,102 9,496 9,723 9,694 9,233 7,450 6,998 6,979 6,344 5,836 96,217
Total
Vaccinated 12,051 13,047 13,811 13,658 14,140 14,849 13,204 12,183 11,219 11,512 11,365 9,825 150,864
Unvaccinated 13,876 16,002 18,106 18,744 19,246 19,097 18,183 15,106 14,162 14,256 13,172 11,952 191,902
Incidence per 100,000 Average Decrease (%)
Women
Vaccinated 46.07 50.59 54.05 54.93 56.92 58.81 54.18 50.21 48.29 46.98 46.79 41.47 50.8 10
Unvaccinated 22.00 25.14 28.97 30.33 30.83 30.05 28.57 24.42 23.80 23.05 21.65 19.36 25.7 12
Men
Vaccinated 58.72 64.53 68.78 67.59 69.64 73.76 65.27 60.14 57.47 57.32 56.91 49.31 62.5 16
Unvaccinated 25.70 29.34 32.13 33.26 33.97 33.79 32.08 25.80 25.19 23.97 21.72 19.92 28.0 23
Total
Vaccinated 52.57 57.75 61.61 61.43 63.39 66.35 59.86 55.29 52.99 52.25 51.94 45.48 56.8 14
Unvaccinated 23.75 27.14 30.47 31.75 32.34 31.84 30.25 25.08 24.47 23.49 21.68 19.63 26.8 17
Fig. 4 Percentage change in the incidence of inpatient treat-
ments for otosclerosis and otitis media between 1993 and 2004. In
comparison of the vaccinated patients (red, up to and including
25 years old) with those deWned as unvaccinated (blue, over
25 years old), a signiWcant decrease of the incidence in the vacci-
nated patients is shown in the group with otosclerosis both in the
group as a whole and in consideration of men and women sepa-
rately. In the otitis media group, the incidence decreased more in
the unvaccinated (blue) than in the vaccinated (red) patients both
in men and women separately and in the overall group123
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men (1.68:1, present study; 1.87:1, Switzerland; 2:1
according to the literature) [12]. A WHO study reports
that throughout the world women die of the complica-
tions of a measles infection more frequently than men
(1.42:1) [41]. Moreover, in West Africa the complications
of measles vaccination occur more frequently in girls
than in boys (1.93:1) [42]. The most plausible hypothesis
to explain this is a genetically determined gender diVer-
ence in the immune response to measles virus infection
[43], an unique infectiological phenomenon.
Conclusion
Between 1993 and 2004 the incidence of hospital treat-
ments for otosclerosis declined to a signiWcantly
greater extent in the vaccinated patient group than in
the unvaccinated. The decrease is much greater in
males than in females. A comparable eVect cannot be
seen in patients with otitis media. These results give
support that the measles viruses are playing a causal
role in the development of otosclerosis. The diVerent
response of the male and female gender may be due to
a diVerent reactivity of the female immune system to
measles viruses.
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